Component
Free N-epsilon-trimethyl-L-lysine
Independent small molecule record; interpretation is limited by each linked claim and its study context.
4 recorded relationships. Experimental role, claim status and evidence remain attached to each record.
How nutrients influence it
Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.
Other things that act on it
Enzymes, hormones, genes, and other components with a recorded effect. These are not nutrients, so they do not count toward the arrows above. Each finding names the chapter that recorded it.
How nutrients reach it in more than one step
Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.
Tracing routes…
What it does
Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.
What it acts on
Human TMLHE hydroxylates free trimethyllysine to (2S,3S)-hydroxytrimethyllysine, coupled to 2-oxoglutarate oxidation.
Experimental context and source evidence
- experimental_model
- Recombinant human TMLH, synthetic standards and NMR; Recombinant human TMLH and substrate analogue assays
- limitations
- The substrate is free trimethyllysine after proteolysis, not ordinary free lysine.
- organism
- Homo sapiens
- plain_language
- TMLHE begins conversion of released trimethyllysine toward carnitine.
- primary_references
- [lesniak2017] Human carnitine biosynthesis proceeds via (2S,3S)-3-hydroxy-Nε-trimethyllysine (2017). https://pmc.ncbi.nlm.nih.gov/articles/PMC5644716/ DOI: 10.1039/C6CC08381A [tmlh2016scope] Substrate scope for trimethyllysine hydroxylase catalysis (2016). https://pubs.rsc.org/en/content/articlehtml/2016/cc/c6cc07845a DOI: 10.1039/C6CC07845A
- tissue_or_cell_type
- Mitochondrial carnitine-biosynthesis step
L-Lysine: mechanism-first literature curation (2026-09-17) · lines 166–175
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Recombinant human TMLH, synthetic standards and NMR; Recombinant human TMLH and substrate analogue assays · source_derived_draft · unverified_draft
### tmlhe-hydroxylation Human TMLHE hydroxylates free trimethyllysine to (2S,3S)-hydroxytrimethyllysine, coupled to 2-oxoglutarate oxidation. Plain language: TMLHE begins conversion of released trimethyllysine toward carnitine. Condition category: normal organism: Homo sapiens tissue_or_cell_type: Mitochondrial carnitine-biosynthesis step experimental_model: Recombinant human TMLH, synthetic standards and NMR; Recombinant human TMLH and substrate analogue assays limitations: The substrate is free trimethyllysine after proteolysis, not ordinary free lysine. [lesniak2017] Human carnitine biosynthesis proceeds via (2S,3S)-3-hydroxy-Nε-trimethyllysine (2017). https://pmc.ncbi.nlm.nih.gov/articles/PMC5644716/ DOI: 10.1039/C6CC08381A [tmlh2016scope] Substrate scope for trimethyllysine hydroxylase catalysis (2016). https://pubs.rsc.org/en/content/articlehtml/2016/cc/c6cc07845a DOI: 10.1039/C6CC07845A
Complete structured claim and evidenceOral trimethyllysine increased urine-based estimated carnitine synthesis by 32–40 micromol/kg/day across ascorbate-replete, deficient and pair-fed guinea-pig groups; vitamin C deficiency did not abolish the precursor response.
Experimental context and source evidence
- availability_state
- nutrient_deficiency Imported condition classification; unverified.
- cross_nutrient
- Vitamin C chemistry in collagen, modified-lysine/carnitine metabolism or copper-dependent peptide/catecholamine processing.
- experimental_model
- Guinea-pig dietary deficiency with pair feeding and precursor loading
- exposure
- Vitamin C deficient diet for 28 days; oral trimethyllysine or gamma-butyrobetaine 0.5 mmol/kg/day on days 19–28, with replete and pair-fed controls.
- limitations
- Estimate is derived from excretion during a large precursor load, not isotope-resolved basal flux; does not show all tissues are vitamin-C-independent.
- nutrient_topic
- Vitamin C research collection; topical membership is not evidence of a direct dietary effect. · Vitamin C
- organism
- Cavia porcellus
- plain_language
- Even vitamin-C-deficient animals could make substantial carnitine when given this precursor.
- primary_references
- [carnitine1995] The ability of guinea pigs to synthesize carnitine at a normal rate from epsilon-N-trimethyllysine or gamma-butyrobetaine in vivo is not compromised by experimental vitamin C deficiency. (1995). https://pubmed.ncbi.nlm.nih.gov/7752911/ DOI: 10.1016/0026-0495(95)90120-5
- tissue_or_cell_type
- Whole animal; urine-based synthesis estimate
- trigger_kind
- nutrient_deficiency Imported condition classification; unverified.
Vitamin C: mechanisms, deficiency and nutrient interactions (2026-09-17) · lines 754–765
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Guinea-pig dietary deficiency with pair feeding and precursor loading · source_derived_draft · unverified_draft
### vc-enzyme-deficient-tml-response Oral trimethyllysine increased urine-based estimated carnitine synthesis by 32–40 micromol/kg/day across ascorbate-replete, deficient and pair-fed guinea-pig groups; vitamin C deficiency did not abolish the precursor response. Condition category: nutrient_deficiency nutrient_topic: Vitamin C research collection; topical membership is not evidence of a direct dietary effect. plain_language: Even vitamin-C-deficient animals could make substantial carnitine when given this precursor. organism: Cavia porcellus tissue_or_cell_type: Whole animal; urine-based synthesis estimate experimental_model: Guinea-pig dietary deficiency with pair feeding and precursor loading limitations: Estimate is derived from excretion during a large precursor load, not isotope-resolved basal flux; does not show all tissues are vitamin-C-independent. cross_nutrient: Vitamin C chemistry in collagen, modified-lysine/carnitine metabolism or copper-dependent peptide/catecholamine processing. exposure: Vitamin C deficient diet for 28 days; oral trimethyllysine or gamma-butyrobetaine 0.5 mmol/kg/day on days 19–28, with replete and pair-fed controls. [carnitine1995] The ability of guinea pigs to synthesize carnitine at a normal rate from epsilon-N-trimethyllysine or gamma-butyrobetaine in vivo is not compromised by experimental vitamin C deficiency. (1995). https://pubmed.ncbi.nlm.nih.gov/7752911/ DOI: 10.1016/0026-0495(95)90120-5
Complete structured claim and evidence
What acts on it
Proteolysis releases free trimethyllysine from trimethyllysine-containing protein, providing a precursor for carnitine biosynthesis.
Experimental context and source evidence
- experimental_model
- Radiolabeled asialofetuin metabolism in rats and perfused rat liver
- limitations
- Direct tracer evidence is rat; do not replace this with a direct free-lysine-to-carnitine edge.
- organism
- Rattus norvegicus
- plain_language
- Protein breakdown releases the modified lysine used to make carnitine.
- primary_references
- [labadie1976] Hepatic synthesis of carnitine from protein-bound trimethyl-lysine. Lysosomal digestion of methyl-lysine-labelled asialo-fetuin (1976). https://pubmed.ncbi.nlm.nih.gov/64247/ DOI: 10.1042/bj1600085
- tissue_or_cell_type
- Liver lysosomes and downstream metabolism
L-Lysine: mechanism-first literature curation (2026-09-17) · lines 156–164
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Radiolabeled asialofetuin metabolism in rats and perfused rat liver · source_derived_draft · unverified_draft
### protein-tml-release Proteolysis releases free trimethyllysine from trimethyllysine-containing protein, providing a precursor for carnitine biosynthesis. Plain language: Protein breakdown releases the modified lysine used to make carnitine. Condition category: normal organism: Rattus norvegicus tissue_or_cell_type: Liver lysosomes and downstream metabolism experimental_model: Radiolabeled asialofetuin metabolism in rats and perfused rat liver limitations: Direct tracer evidence is rat; do not replace this with a direct free-lysine-to-carnitine edge. [labadie1976] Hepatic synthesis of carnitine from protein-bound trimethyl-lysine. Lysosomal digestion of methyl-lysine-labelled asialo-fetuin (1976). https://pubmed.ncbi.nlm.nih.gov/64247/ DOI: 10.1042/bj1600085
Complete structured claim and evidence
Where it participates (unsigned role)
Omission controls with recombinant human MBP-TMLH-a showed that ascorbate, Fe(II) and 2-oxoglutarate were each needed for efficient conversion of free trimethyllysine to 3-hydroxytrimethyllysine.
Experimental context and source evidence
- cross_nutrient
- Vitamin C + iron support hydroxylation of a modified lysine precursor; downstream existing SHMT steps use B6-derived PLP and ALDH9A1 uses NAD+.
- experimental_model
- Recombinant human MBP-TMLH-a; mass spectrometry and NMR
- exposure
- 500 micromolar trimethyllysine and 3 micromolar enzyme, FeSO4/2OG/ascorbate, 37 C for 30 minutes; cofactor omission controls.
- limitations
- New record isolates the ascorbate cofactor dependence; the existing substrate-to-product UUID is reused. Fusion-protein assay does not quantify whole-body flux.
- nutrient_topic
- Vitamin C research collection; topical membership is not evidence of a direct dietary effect. · Vitamin C
- organism
- Homo sapiens
- plain_language
- The first carnitine-synthesis hydroxylation needs vitamin C support alongside iron and 2-oxoglutarate.
- primary_references
- [tmlh2016] Substrate scope for trimethyllysine hydroxylase catalysis. (2016). https://pubmed.ncbi.nlm.nih.gov/27730239/ DOI: 10.1039/c6cc07845a
- tissue_or_cell_type
- Cell-free recombinant enzyme
Vitamin C: mechanisms, deficiency and nutrient interactions (2026-09-17) · lines 689–700
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Recombinant human MBP-TMLH-a; mass spectrometry and NMR · source_derived_draft · unverified_draft
### vc-enzyme-tmlh-ascorbate-dependency Omission controls with recombinant human MBP-TMLH-a showed that ascorbate, Fe(II) and 2-oxoglutarate were each needed for efficient conversion of free trimethyllysine to 3-hydroxytrimethyllysine. Condition category: normal nutrient_topic: Vitamin C research collection; topical membership is not evidence of a direct dietary effect. plain_language: The first carnitine-synthesis hydroxylation needs vitamin C support alongside iron and 2-oxoglutarate. organism: Homo sapiens tissue_or_cell_type: Cell-free recombinant enzyme experimental_model: Recombinant human MBP-TMLH-a; mass spectrometry and NMR limitations: New record isolates the ascorbate cofactor dependence; the existing substrate-to-product UUID is reused. Fusion-protein assay does not quantify whole-body flux. cross_nutrient: Vitamin C + iron support hydroxylation of a modified lysine precursor; downstream existing SHMT steps use B6-derived PLP and ALDH9A1 uses NAD+. exposure: 500 micromolar trimethyllysine and 3 micromolar enzyme, FeSO4/2OG/ascorbate, 37 C for 30 minutes; cofactor omission controls. [tmlh2016] Substrate scope for trimethyllysine hydroxylase catalysis. (2016). https://pubmed.ncbi.nlm.nih.gov/27730239/ DOI: 10.1039/c6cc07845a
Complete structured claim and evidence
The events it takes part in
A mechanism often involves more than two components. These are the full events, with every participant and its role.
Situations it appears in
Low-supply and faulty-machinery situations recorded in the chapters where this component plays a part.
In the sources
Preserved passages that mention this component, quoted exactly. Open one to read it in context.
Open hypotheses
Proposed ideas that involve this component. They are labeled as hypotheses and do not change any recorded statement.
This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.